Analysts at StockNews.com started coverage on shares of NovaBay Pharmaceuticals (NYSE:NBY – Get Free Report) in a research report issued to clients and investors on Monday. The firm set a “hold” rating on the stock.
NovaBay Pharmaceuticals Stock Performance
Shares of NYSE:NBY opened at $0.63 on Monday. The business has a 50-day simple moving average of $0.66 and a two-hundred day simple moving average of $0.63. The firm has a market cap of $3.08 million, a price-to-earnings ratio of -0.01 and a beta of 0.73. NovaBay Pharmaceuticals has a fifty-two week low of $0.36 and a fifty-two week high of $9.08.
NovaBay Pharmaceuticals Company Profile
Read More
- Five stocks we like better than NovaBay Pharmaceuticals
- Short Selling: How to Short a Stock
- How to Build the Ultimate Everything ETF Portfolio
- How to Plot Fibonacci Price Inflection Levels
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- The Risks of Owning Bonds
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for NovaBay Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovaBay Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.